Sakar Healthcare Limited (SAKAR) - Total Assets
Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) holds total assets worth Rs4.81 Billion INR (≈ $52.02 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sakar Healthcare Limited - Total Assets Trend (2010–2026)
This chart illustrates how Sakar Healthcare Limited's total assets have evolved over time, based on quarterly financial data. Also see Sakar Healthcare Limited (SAKAR) total market value for the company's overall valuation and market capitalisation.
Sakar Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Sakar Healthcare Limited's total assets of Rs4.81 Billion consist of 29.2% current assets and 70.8% non-current assets. Review total liabilities of Sakar Healthcare Limited to assess the company's total debt and financial obligations.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.1% |
| Accounts Receivable | Rs500.83 Million | 10.4% |
| Inventory | Rs700.41 Million | 14.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs74.27 Million | 1.5% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2010–2026)
This chart illustrates how Sakar Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See SAKAR stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sakar Healthcare Limited's current assets represent 29.2% of total assets in 2026, a decrease from 30.9% in 2010.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2026, down from 0.6% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 14.6% of total assets.
Sakar Healthcare Limited Competitors by Total Assets
Key competitors of Sakar Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Sakar Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.28 | 1.40 | 1.01 |
| Quick Ratio | 0.64 | 0.71 | 0.54 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs309.21 Million | Rs255.41 Million | Rs4.54 Million |
Sakar Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Sakar Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.26 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 15.8% |
| Total Assets | Rs4.81 Billion |
| Market Capitalization | $280.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sakar Healthcare Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Sakar Healthcare Limited's assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sakar Healthcare Limited (2010–2026)
The table below shows the annual total assets of Sakar Healthcare Limited from 2010 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs4.81 Billion ≈ $52.02 Million |
+15.83% |
| 2025-03-31 | Rs4.15 Billion ≈ $44.91 Million |
+6.84% |
| 2024-03-31 | Rs3.89 Billion ≈ $42.03 Million |
+15.56% |
| 2023-03-31 | Rs3.36 Billion ≈ $36.37 Million |
+25.61% |
| 2022-03-31 | Rs2.68 Billion ≈ $28.96 Million |
+50.61% |
| 2021-03-31 | Rs1.78 Billion ≈ $19.23 Million |
+54.44% |
| 2020-03-31 | Rs1.15 Billion ≈ $12.45 Million |
+16.66% |
| 2019-03-31 | Rs986.85 Million ≈ $10.67 Million |
+21.68% |
| 2018-03-31 | Rs811.00 Million ≈ $8.77 Million |
+14.89% |
| 2017-03-31 | Rs705.87 Million ≈ $7.63 Million |
+38.11% |
| 2016-03-31 | Rs511.10 Million ≈ $5.53 Million |
+1.86% |
| 2015-03-31 | Rs501.75 Million ≈ $5.43 Million |
-4.13% |
| 2014-03-31 | Rs523.37 Million ≈ $5.66 Million |
+4.48% |
| 2013-03-31 | Rs500.94 Million ≈ $5.42 Million |
+0.35% |
| 2012-03-31 | Rs499.20 Million ≈ $5.40 Million |
+2.11% |
| 2011-03-31 | Rs488.89 Million ≈ $5.29 Million |
+9.29% |
| 2010-03-31 | Rs447.35 Million ≈ $4.84 Million |
-- |
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more